Dry Powder Inhalers II: Enhancing bioavailability through product design (Pharmaceuticals Trai)
Venue: Online Event
|Event Date/Time: Jun 10, 2011||End Date/Time: Jun 10, 2011|
Drug action when delivered through a dry powder inhaler device is closely related to both physical considerations and chemical interactions between the interface, between well defined inhaled particles and the respiratory tract surface . Many patented products developed in this area takes into account the spherical shape and also hollow characteristics of carrier particles.
No attempts have been made till now to combine a carrier with usual aerodynamic diameter and develop active spherical particles that can be adhered to the carrier with and adhesion force similar to those obtained with a traditional powder mix. Impact on bioavailability is in close relationship with both carrier and active particle design and formulation.
Areas Covered in the Seminar:
- API particle size and shape.
- How to control those parameters.
- Formulating spherical particles.
- Optimizing formulations to achieve reproducibility.
- Strategies to enhance drug bioavailability.
- Device and product impact on bioavailability.
NOTE: Use This Promocode ( 117660 ) To Get 10% Discount.